Home » Stocks » VAR

Varian Medical Systems, Inc. (VAR)

Stock Price: $174.12 USD 0.62 (0.36%)
Updated November 24, 4:04 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 15.87B
Revenue (ttm) 3.20B
Net Income (ttm) 263.30M
Shares Out 91.16M
EPS (ttm) 2.94
PE Ratio 59.22
Forward PE 32.05
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 24
Last Price $174.12
Previous Close $173.50
Change ($) 0.62
Change (%) 0.36%
Day's Open 174.00
Day's Range 174.00 - 174.27
Day's Volume 1,729,388
52-Week Range 89.62 - 176.19

More Stats

Market Cap 15.87B
Enterprise Value 15.79B
Earnings Date (est) Jan 27, 2021
Ex-Dividend Date n/a
Shares Outstanding 91.16M
Float 90.91M
EPS (basic) 2.90
EPS (diluted) 2.94
FCF / Share 2.93
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.69%
FCF Yield 1.68%
Payout Ratio n/a
Shares Short 2.21M
Short Ratio 1.98
Short % of Float 2.43%
Beta 1.17
PE Ratio 59.22
Forward PE 32.05
P/FCF Ratio 59.67
PS Ratio 4.97
PB Ratio 7.62
Revenue 3.20B
Operating Income 335.60M
Net Income 263.30M
Free Cash Flow 266.00M
Net Cash 86.60M
Net Cash / Share 0.95
Gross Margin 43.47%
Operating Margin 10.50%
Profit Margin 8.20%
FCF Margin 8.32%
ROA 6.20%
ROE 13.95%
ROIC 27.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (6)

Buy 0
Overweight 0
Hold 5
Underweight 0
Sell 1

Analyst Consensus: Hold

Price Target

$177.67*
(2.04% upside)
Low
178
Current: $174.12
High
178
Target: 177.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue3,2252,9192,6192,5942,4913,0502,9432,8072,5972,357
Revenue Growth10.48%11.45%0.99%4.14%-18.33%3.63%4.84%8.1%10.19%-
Gross Profit1,3701,2741,1141,1051,0321,3021,2501,1961,1361,026
Operating Income386437298427396571609594588534
Net Income292150219399412404438427399360
Shares Outstanding91.0091.5092.5095.4099.70104108111117122
Earnings Per Share3.181.622.354.164.093.833.983.763.362.91
EPS Growth96.3%-31.06%-43.51%1.71%6.79%-3.77%5.85%11.9%15.46%-
Operating Cash Flow372455399356470449455493473461
Capital Expenditures-58.00-47.70-59.10-80.40-91.40-89.60-76.28-61.10-70.93-67.55
Free Cash Flow314407340276378359379432402393
Cash & Equivalents5315057169078469151,181754584520
Total Debt410-35066649643850616119843.39
Net Cash / Debt121505366241350478674593386477
Assets4,1023,2533,2943,8153,5793,3573,4682,8792,4992,324
Liabilities2,3241,6641,7732,0601,8521,7411,7551,3691,2551,049
Book Value1,7681,5841,5181,7411,7121,6161,7141,5101,2441,275
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Varian Medical Systems, Inc.
Country United States
Employees 10,000
CEO Dow R. Wilson

Stock Information

Ticker Symbol VAR
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSE: VAR

Description

Varian Medical Systems designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with Siemens AG; partnership agreement with The National University Cancer Institute; and a strategic collaboration with Telix Pharmaceuticals for advanced prostate imaging. Varian Medical Systems was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.